Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 306 | 3 | INTEGRIN//OSTEOPONTIN//MATRIX METALLOPROTEINASE | 40954 |
| 587 | 2 | INTEGRIN//FOCAL ADHESION KINASE//TENASCIN C | 14663 |
| 38057 | 1 | RECOMBINANT FIBRONECTIN FRAGMENT//CBD HEPII POLYPEPTIDE//ARG GLY ASP SER RGDS | 70 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | RECOMBINANT FIBRONECTIN FRAGMENT | authKW | 2251224 | 7% | 100% | 5 |
| 2 | CBD HEPII POLYPEPTIDE | authKW | 900490 | 3% | 100% | 2 |
| 3 | ARG GLY ASP SER RGDS | authKW | 675364 | 4% | 50% | 3 |
| 4 | ASAKA S | address | 600325 | 3% | 67% | 2 |
| 5 | ADENOID CYSTIC CARCINOMA ACE | authKW | 450245 | 1% | 100% | 1 |
| 6 | ARG GLY ASP SER ANALOG | authKW | 450245 | 1% | 100% | 1 |
| 7 | ARG GLY ASP SER RGDS ANALOGUE | authKW | 450245 | 1% | 100% | 1 |
| 8 | ARG LEU ASP SER RLDS ANALOGUE | authKW | 450245 | 1% | 100% | 1 |
| 9 | CBD AND HEPII DOMAINS | authKW | 450245 | 1% | 100% | 1 |
| 10 | EILDV | authKW | 450245 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 574 | 47% | 0% | 33 |
| 2 | Medicine, Research & Experimental | 54 | 11% | 0% | 8 |
| 3 | Pharmacology & Pharmacy | 47 | 17% | 0% | 12 |
| 4 | Biochemistry & Molecular Biology | 27 | 20% | 0% | 14 |
| 5 | Biophysics | 12 | 6% | 0% | 4 |
| 6 | Polymer Science | 10 | 6% | 0% | 4 |
| 7 | Chemistry, Applied | 10 | 4% | 0% | 3 |
| 8 | Gastroenterology & Hepatology | 3 | 3% | 0% | 2 |
| 9 | Materials Science, Biomaterials | 3 | 1% | 0% | 1 |
| 10 | Medicine, General & Internal | 2 | 4% | 0% | 3 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ASAKA S | 600325 | 3% | 67% | 2 |
| 2 | IMMUNOL SCI KITA15 NISHI7 KITA KU | 450245 | 1% | 100% | 1 |
| 3 | INTER EGIATE BIOTECHNOL MED | 450245 | 1% | 100% | 1 |
| 4 | MOL CELLULAR PATHOL PATHOPHYSIOL | 450245 | 1% | 100% | 1 |
| 5 | PATHOGEN BIOCHEM WAKAN YAKU | 450245 | 1% | 100% | 1 |
| 6 | WAKAN YAKU TRAD SINO J ANESE MED | 450245 | 1% | 100% | 1 |
| 7 | IMMUNOL SCI KITA 15 NISHI 7 KITA KU | 225121 | 1% | 50% | 1 |
| 8 | RADIOBIOCHEM PHARMACEUT SCI | 225121 | 1% | 50% | 1 |
| 9 | SCI POLYMER SCI KITA KU | 180095 | 3% | 20% | 2 |
| 10 | ASHIGARA S | 139720 | 9% | 5% | 6 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JAPANESE JOURNAL OF CANCER RESEARCH | 10305 | 13% | 0% | 9 |
| 2 | CLINICAL & EXPERIMENTAL METASTASIS | 3555 | 6% | 0% | 4 |
| 3 | CLINICAL IMMUNOTHERAPEUTICS | 1792 | 1% | 0% | 1 |
| 4 | ONCOLOGY RESEARCH | 1391 | 3% | 0% | 2 |
| 5 | ACTA PHARMACOLOGICA SINICA | 706 | 4% | 0% | 3 |
| 6 | ANTI-CANCER DRUGS | 536 | 3% | 0% | 2 |
| 7 | PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY | 509 | 1% | 0% | 1 |
| 8 | JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS | 491 | 1% | 0% | 1 |
| 9 | CELLULAR & MOLECULAR BIOLOGY LETTERS | 437 | 1% | 0% | 1 |
| 10 | ARCHIVES OF HISTOLOGY AND CYTOLOGY | 408 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |